Literature DB >> 9178708

American Gastroenterological Association medical position statement: irritable bowel syndrome.

.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9178708     DOI： 10.1053/gast.1997.1122118

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  13 in total

Review 1.  Drug treatment options for irritable bowel syndrome: managing for success.

Authors:  R C Dunphy; G N Verne
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 2.  Tegaserod.

Authors:  L J Scott; C M Perry
Journal:  Drugs       Date:  1999-09       Impact factor: 9.546

Review 3.  Irritable bowel syndrome: new agents targeting serotonin receptor subtypes.

Authors:  F De Ponti; M Tonini
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 4.  Does coeliac disease affect colorectal practice?

Authors:  David S Sanders; David P Hurlstone; Steve Brown
Journal:  Int J Colorectal Dis       Date:  2006-11-14       Impact factor: 2.571

5.  The Differences in Prevalence and Sociodemographic Characteristics of Irritable Bowel Syndrome According to Rome II and Rome III.

Authors:  Dong Won Park; Oh Young Lee; Sung Gon Shim; Dae Won Jun; Kang Nyeong Lee; Hye Young Kim; Hang Lak Lee; Byung Chul Yoon; Ho Soon Choi
Journal:  J Neurogastroenterol Motil       Date:  2010-04-28       Impact factor: 4.924

Review 6.  Tegaserod: a review of its use in the management of irritable bowel syndrome with constipation in women.

Authors:  Antona J Wagstaff; James E Frampton; Katherine F Croom
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 7.  Advances in the management of irritable bowel syndrome.

Authors:  Brooks D Cash; William D Chey
Journal:  Curr Gastroenterol Rep       Date:  2003-12

8.  High-fiber diet supplementation in patients with irritable bowel syndrome (IBS): a multicenter, randomized, open trial comparison between wheat bran diet and partially hydrolyzed guar gum (PHGG).

Authors:  G C Parisi; M Zilli; M P Miani; M Carrara; E Bottona; G Verdianelli; G Battaglia; S Desideri; A Faedo; C Marzolino; A Tonon; M Ermani; G Leandro
Journal:  Dig Dis Sci       Date:  2002-08       Impact factor: 3.199

9.  Irritable bowel syndrome and risk of colorectal cancer: a Danish nationwide cohort study.

Authors:  M Nørgaard; D K Farkas; L Pedersen; R Erichsen; Z D de la Cour; H Gregersen; H T Sørensen
Journal:  Br J Cancer       Date:  2011-02-22       Impact factor: 7.640

10.  Linaclotide.

Authors:  Dennis J Cada; Terri L Levien; Danial E Baker
Journal:  Hosp Pharm       Date:  2013-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.